Medpace Holdings Management
Management criteria checks 4/4
Medpace Holdings' CEO is August Troendle, appointed in Jul 1992, has a tenure of 31.83 years. total yearly compensation is $1.65M, comprised of 49.5% salary and 50.5% bonuses, including company stock and options. directly owns 17.47% of the company’s shares, worth €1.98B. The average tenure of the management team and the board of directors is 5.3 years and 5.8 years respectively.
Key information
August Troendle
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 49.5% |
| CEO tenure | 31.8yrs |
| CEO ownership | 17.5% |
| Management average tenure | 5.3yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$312m |
| Dec 31 2023 | US$2m | US$814k | US$283m |
| Sep 30 2023 | n/a | n/a | US$273m |
| Jun 30 2023 | n/a | n/a | US$268m |
| Mar 31 2023 | n/a | n/a | US$257m |
| Dec 31 2022 | US$2m | US$770k | US$245m |
| Sep 30 2022 | n/a | n/a | US$227m |
| Jun 30 2022 | n/a | n/a | US$209m |
| Mar 31 2022 | n/a | n/a | US$199m |
| Dec 31 2021 | US$6m | US$697k | US$181m |
| Sep 30 2021 | n/a | n/a | US$182m |
| Jun 30 2021 | n/a | n/a | US$175m |
| Mar 31 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$4m | US$608k | US$145m |
| Sep 30 2020 | n/a | n/a | US$124m |
| Jun 30 2020 | n/a | n/a | US$107m |
| Mar 31 2020 | n/a | n/a | US$110m |
| Dec 31 2019 | US$8m | US$504k | US$100m |
| Sep 30 2019 | n/a | n/a | US$93m |
| Jun 30 2019 | n/a | n/a | US$88m |
| Mar 31 2019 | n/a | n/a | US$78m |
| Dec 31 2018 | US$528k | US$420k | US$73m |
| Sep 30 2018 | n/a | n/a | US$61m |
| Jun 30 2018 | n/a | n/a | US$52m |
| Mar 31 2018 | n/a | n/a | US$45m |
| Dec 31 2017 | US$598k | US$419k | US$39m |
Compensation vs Market: August's total compensation ($USD1.65M) is below average for companies of similar size in the German market ($USD5.06M).
Compensation vs Earnings: August's compensation has been consistent with company performance over the past year.
CEO
August Troendle (67 yo)
31.8yrs
Tenure
US$1,646,031
Compensation
Dr. August James Troendle, M.D. has been the Chairman, Chief Executive Officer at Medpace Holdings, Inc. since July 1992 and served as its President since July 1992 until August 01, 2021. Dr. Troendle foun...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 31.8yrs | US$1.65m | 17.47% $ 2.0b | |
| President | 2.8yrs | US$945.08k | 0.070% $ 7.9m | |
| CFO & Treasurer | 5.3yrs | US$690.48k | 0.019% $ 2.2m | |
| Executive Vice President of Operations | 7.3yrs | US$1.12m | 0.049% $ 5.6m | |
| Chief Compliance Officer | 11.9yrs | US$914.64k | 0.043% $ 4.9m | |
| Chief Information Officer | 3.3yrs | no data | no data | |
| Associate Director of Investors Relations | no data | no data | no data | |
| Vice President of Business Development & Marketing | no data | no data | no data | |
| Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | no data | no data | no data | |
| Chief Medical Officer of Medical Department | 1.3yrs | no data | no data |
5.3yrs
Average Tenure
57yo
Average Age
Experienced Management: 01P's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 31.8yrs | US$1.65m | 17.47% $ 2.0b | |
| Lead Independent Director | 5.8yrs | US$264.98k | 0.0065% $ 733.1k | |
| Independent Director | 5.8yrs | US$217.48k | 0.017% $ 1.9m | |
| Independent Director | 7.8yrs | US$227.35k | 0.0014% $ 164.3k | |
| Independent Director | 7.8yrs | US$234.97k | 0.070% $ 7.9m | |
| Independent Director | 1.3yrs | US$258.37k | 0% $ 0 | |
| Independent Director | 5yrs | US$209.98k | 0.00081% $ 91.8k |
5.8yrs
Average Tenure
63yo
Average Age
Experienced Board: 01P's board of directors are considered experienced (5.8 years average tenure).